El Salvador Pharmaceuticals & Healthcare Q1 2021
The pharmaceutical market in El Salvador remains mostly unattractive for multinational drugmakers, as the country'ssmall market size, low per capita spending and weak security environment continue to pose barriers for investment. Despite this,opportunities exist in specific therapeutic niches, such as oncology, where companies that support El Salvador in addressing itscancer crisis will be rewarded with a position in a growing market. Though Bukele has significantly increased funding to the Ministryof Health to combat Covid-19, ongoing allegations of corruption and a major recession in El Salvador will undermine governmentsupport going forward.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook